Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN39045408
ISRCTN39045408
Completed
Not Applicable

Anti-tumour necrosis factor therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over two years

Karolinska University Hospital (Sweden)0 sites40 target enrollmentApril 6, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Karolinska University Hospital (Sweden)
Enrollment
40
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 6, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Karolinska University Hospital (Sweden)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with early RA (disease duration less than 12 months)
  • •2\. Participated in the Swefot (SWEdish PHarmacOTherapy) study at Karolinska University Hospital at Huddinge
  • •3\. Patients started treatment with methotrexate
  • •4\. Active disease defined as a Disease Activity Score of 28 joints (DAS28\) above 3\.2
  • •5\. Aged between 18 and 80 years, either sex

Exclusion Criteria

  • •1\. Prior DMARD therapy
  • •2\. Contraindication to any of the trial medications

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Impact of anti-tumor necrosis factor antibodies treatment on the semen quality of inflammatory bowel diseases patientsfertilityreproduction10013356
NL-OMON33788Erasmus MC, Universitair Medisch Centrum Rotterdam20
Active, not recruiting
Not Applicable
Impact of anti-tumor necrosis factors antibodies treatment on fertility of inflammatory bowel diseases male patientsFertility influenced by antiTNF treatmentMedDRA version: 9.1Level: LLTClassification code 10016469Term: Fertility investigations
EUCTR2008-005619-16-NLErasmus Medical Center
Completed
Not Applicable
Effect of anti-tumour necrosis factor alpha (TNFa) therapy on blood vessel health in patients with rheumatoid arthritisRheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritis
ISRCTN57761809niversity of Dundee (UK)90
Completed
Not Applicable
Effect of 8 weeks of Pilates exercise and vitamin D on Tumor necrosis factor-a and interleukin-10 levels in overweight meObesity and overweight.Obesity due to excess caloriesE66.0
IRCT20190831044650N2Qaemshahr branch, Islamic Azad University56
Active, not recruiting
Phase 1
To see whether for patients with established rheumatoid arthritis that have already achieved a good response to Tumour Necrosis Factor Inhibitor (TNF inhibitor) treatment, whether the treatment be tapered to a minimum dose without affecting the control of disease activity.
EUCTR2010-020738-24-GBKing's College London97